[Bifractionated radiotherapy and oropharyngeal carcinoma].
The relatively poor results of therapy for epidermoid oropharyngeal carcinoma stages T3 and T4 suggested the need for new treatment regimens. A study involving 24 patients included bifractionated radiation on a daily basis, as used by J. C. Horiot and A. Nabib and then by the E.O.R.T.C. group. The more encouraging results reported by A. Nabib were not obtained. The 5-year survival rate will possibly be no better than after conventional external radiation. Post-radiotherapy complications were observed.
D000368:Aged; D002294:Carcinoma, Squamous Cell / Q000532:radiotherapy*; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D008297:Male; D008722:Methods; D008875:Middle Aged; D010610:Pharyngeal Neoplasms / Q000532:radiotherapy*; D011379:Prognosis
Radiothérapie bifractionnée et carcinomes de l'oropharynx.